Another recurrent mutation in AML, especially in older children and adolescents, is that involving the gene CCAAT-enhancer binding protein alpha (C/EBPA), present in 5–10% of pediatric AML cases [12]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.